Susanne Schaffert

Director, Rubius Therapeutics (United States).

Companies

BioNTechBoard member Jun 26, 2026 to now¹
IncyteBoard member Oct 5, 2022 to now²
Rubius Therapeutics (United States)Board member Jul 19, 2022 to Aug 1, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Incyte INCY7,389 shares⁴$840.6K at $113.77Jun 10, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 10, 2025Granted 2,518 shares of Incyte⁴
Jun 10, 2025Shares withheld for tax 849 shares at $70.07 of Incyte⁴
Jun 12, 2024Granted 2,830 shares of Incyte⁵
Jun 12, 2024Shares withheld for tax 752 shares at $59.94 of Incyte⁵
Jun 14, 2023Shares withheld for tax 488 shares at $61.44 of Incyte⁶
Jun 14, 2023Granted 2,505 shares of Incyte⁶
Oct 3, 2022Granted 1,625 shares of Incyte⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBioNTech, Board member
2
SEC EDGARIncyte, Board member
3
SEC EDGARRubius Therapeutics (United States), Board member
4
SEC EDGARIncyte shares after the filing of Jun 10, 2025
5
SEC EDGARForm 4 filed Jun 14, 2024
6
SEC EDGARForm 4 filed Jun 16, 2023
7
SEC EDGARForm 4 filed Oct 5, 2022